Resources
Press Releases
Cascade in the News
Cascade Chemistry selected to produce active pharmaceutical ingredient for clinical trial supplies of COVID-19 investigational drug RBT-9
―Renibus Therapeutics Will Conduct Phase 2 Trial of Compound With Antiviral and Immune-Modulating Activity― Eugene, OR – June 16, 2020 – Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical...